<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40944179</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>17</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Citrulline Supplementation Improves Microvascular Function and Muscle Strength in Middle-Aged and Older Adults with Type 2 Diabetes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2790</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu17172790</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with type 2 diabetes (T2D) develop vascular complications due to arginine deficiency-induced microvascular endothelial dysfunction, which is related to the loss of muscle strength (MS) associated with aging. Thus, increased nitric oxide (NO)-mediated vasodilation may improve MS. We investigated the impact of the NO precursor citrulline on microvascular function (endothelial and muscle reactivity) and MS in T2D patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixteen participants with T2D (53-72 years, nine females) were randomized to citrulline supplementation (CITS, 6 g/day) or placebo for 4 weeks prior to an 8-week washout period, followed by the opposite supplement for 4 weeks in a crossover trial. Endothelial function (log-transformed reactive hyperemia index, LnRHI), forearm muscle reactivity (near-infrared spectroscopy-derived tissue oxygen index (TOI) reperfusion indices), plasma arginine levels (ARG), and handgrip strength (HGS<sub>rel</sub>) and calf MS (CMS<sub>rel</sub>) adjusted for body weight were measured at baseline and 4 weeks for each condition.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">CITS increased the LnRHI (&#x2206;0.11 &#xb1; 0.16 vs. &#x2206;-0.08 &#xb1; 0.24, <i>p</i> &lt; 0.05), TOI range (&#x2206;2.6 &#xb1; 3.3 vs. &#x2206;-1.5 &#xb1; 4.8%, <i>p</i> &lt; 0.01), TOI hyperemic response (&#x2206;1.2 &#xb1; 1.4 vs. &#x2206;-0.6 &#xb1; 2.8%, <i>p</i> &lt; 0.05), TOI 2 min area under the curve (&#x2206;154 &#xb1; 187 vs. &#x2206;-41 &#xb1; 194%/s, <i>p</i> &lt; 0.01), ARG (&#x2206;43 &#xb1; 28 vs. &#x2206;1 &#xb1; 16&#x3bc;M/L, <i>p</i> &lt; 0.001), CMS (&#x2206;1.5 &#xb1; 2.8 vs. &#x2206;-0.3 &#xb1; 1.2 kg, <i>p</i> &lt; 0.05), and CMS<sub>rel</sub> (&#x2206;0.02 &#xb1; 0.03 vs. &#x2206;-0.01 &#xb1; 0.02 kg/kg, <i>p</i> &lt; 0.01) compared to placebo. The improvements in LnRHI and CMS<sub>rel</sub> were correlated (<i>r</i> = 0.37, <i>p</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study showed that CITS improves microvascular endothelial function, muscle microvascular reactivity, and calf muscle strength in middle-aged and older patients with T2D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Figueroa</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9710-038X</Identifier><AffiliationInfo><Affiliation>Department of Kinesiology and Sport Management, Texas Tech University, Lubbock, TX 79409, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillon</LastName><ForeName>Katherine N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Kinesiology and Sport Management, Texas Tech University, Lubbock, TX 79409, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Kinesiology, Albion College, Albion, MI 49224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levitt</LastName><ForeName>Danielle E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0003-1865-1971</Identifier><AffiliationInfo><Affiliation>Department of Kinesiology and Sport Management, Texas Tech University, Lubbock, TX 79409, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Yejin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3436-1846</Identifier><AffiliationInfo><Affiliation>Department of Kinesiology and Sport Management, Texas Tech University, Lubbock, TX 79409, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Pharmacology &amp; Therapeutics, University of British Columbia (UBC), Vancouver, BC V6T 1Z3, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>29VT07BGDA</RegistryNumber><NameOfSubstance UI="D002956">Citrulline</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002956" MajorTopicYN="Y">Citrulline</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="Y">Muscle Strength</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055806" MajorTopicYN="Y">Microvessels</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="Y">Microcirculation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arginine precursor</Keyword><Keyword MajorTopicYN="N">muscle tissue oxygen saturation</Keyword><Keyword MajorTopicYN="N">peripheral artery tonometry</Keyword><Keyword MajorTopicYN="N">reactive hyperemia index</Keyword><Keyword MajorTopicYN="N">vascular aging</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40944179</ArticleId><ArticleId IdType="pmc">PMC12430577</ArticleId><ArticleId IdType="doi">10.3390/nu17172790</ArticleId><ArticleId IdType="pii">nu17172790</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Jager J., Dekker J.M., Kooy A., Kostense P.J., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: The Hoorn Study. Arterioscler. Thromb. Vasc. Biol. 2006;26:1086&#x2013;1093. doi: 10.1161/01.ATV.0000215951.36219.a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000215951.36219.a4</ArticleId><ArticleId IdType="pubmed">16514084</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett E.J., Liu Z., Khamaisi M., King G.L., Klein R., Klein B.E.K., Hughes T.M., Craft S., Freedman B.I., Bowden D.W., et al. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J. Clin. Endocrinol. Metab. 2017;102:4343&#x2013;4410. doi: 10.1210/jc.2017-01922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2017-01922</ArticleId><ArticleId IdType="pmc">PMC5718697</ArticleId><ArticleId IdType="pubmed">29126250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahad O., Wild P.S., Prochaska J.H., Schulz A., Hermanns I., Lackner K.J., Pfeiffer N., Schmidtmann I., Beutel M., Gori T. Endothelial function assessed by digital volume plethysmography predicts the development and progression of type 2 diabetes mellitus. J. Am. Heart Assoc. 2019;8:e012509. doi: 10.1161/JAHA.119.012509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.012509</ArticleId><ArticleId IdType="pmc">PMC6818038</ArticleId><ArticleId IdType="pubmed">31583936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M., Gomes M.B., Nicolucci A., Pocock S., Rathmann W., Shestakova M.V., Watada H., Shimomura I., Chen H., Cid-Ruzafa J., et al. Vascular complications in patients with type 2 diabetes: Prevalence and associated factors in 38 countries (the DISCOVER study program) Cardiovasc. Diabetol. 2018;17:150. doi: 10.1186/s12933-018-0787-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-018-0787-8</ArticleId><ArticleId IdType="pmc">PMC6260731</ArticleId><ArticleId IdType="pubmed">30486889</ArticleId></ArticleIdList></Reference><Reference><Citation>Jojima T., Kurai H., Tanuma D., Kajitani H., Kase M., Inoue Y., Sakurai S., Iijima T., Tomaru T., Usui I., et al. Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes. Int. J. Cardiol. Heart Vasc. 2022;41:101071. doi: 10.1016/j.ijcha.2022.101071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101071</ArticleId><ArticleId IdType="pmc">PMC9213220</ArticleId><ArticleId IdType="pubmed">35757147</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.W., Goodpaster B.H., Strotmeyer E.S., Kuller L.H., Broudeau R., Kammerer C., de Rekeneire N., Harris T.B., Schwartz A.V., Tylavsky F.A., et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: The health, aging, and body composition study. Diabetes Care. 2007;30:1507&#x2013;1512. doi: 10.2337/dc06-2537.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-2537</ArticleId><ArticleId IdType="pubmed">17363749</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenders M., Verdijk L.B., van der Hoeven L., Adam J.J., van Kranenburg J., Nilwik R., van Loon L.J. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J. Am. Med. Dir. Assoc. 2013;14:585&#x2013;592. doi: 10.1016/j.jamda.2013.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2013.02.006</ArticleId><ArticleId IdType="pubmed">23537893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvoretskiy S., Lieblein-Boff J.C., Jonnalagadda S., Atherton P.J., Phillips B.E., Pereira S.L. Exploring the association between vascular dysfunction and skeletal muscle mass, strength and function in healthy adults: A systematic review. Nutrients. 2020;12:715. doi: 10.3390/nu12030715.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12030715</ArticleId><ArticleId IdType="pmc">PMC7146456</ArticleId><ArticleId IdType="pubmed">32156061</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu B.G., Wang C.H., Lai Y.H., Kuo C.H., Lin Y.L. Association of endothelial dysfunction and peripheral arterial disease with sarcopenia in chronic kidney disease. J. Cachexia Sarcopenia Muscle. 2024;15:1199&#x2013;1208. doi: 10.1002/jcsm.13471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.13471</ArticleId><ArticleId IdType="pmc">PMC11154745</ArticleId><ArticleId IdType="pubmed">38644163</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffernan K.S., Chal&#xe9; A., Hau C., Cloutier G.J., Phillips E.M., Warner P., Nickerson H., Reid K.F., Kuvin J.T., Fielding R.A. Systemic vascular function is associated with muscular power in older adults. J. Aging Res. 2012;2012:386387. doi: 10.1155/2012/386387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/386387</ArticleId><ArticleId IdType="pmc">PMC3433136</ArticleId><ArticleId IdType="pubmed">22966457</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo J.I., Kim M.J., Na J.B., Chun Y.H., Park Y.J., Park Y., Hah Y.S., Ha Y.C., Park K.S. Relationship between endothelial function and skeletal muscle strength in community dwelling elderly women. J. Cachexia Sarcopenia Muscle. 2018;9:1034&#x2013;1041. doi: 10.1002/jcsm.12340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12340</ArticleId><ArticleId IdType="pmc">PMC6240755</ArticleId><ArticleId IdType="pubmed">30084166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamburg N.M., Keyes M.J., Larson M.G., Vasan R.S., Schnabel R., Pryde M.M., Mitchell G.F., Sheffy J., Vita J.A., Benjamin E.J. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117:2467&#x2013;2474. doi: 10.1161/CIRCULATIONAHA.107.748574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.748574</ArticleId><ArticleId IdType="pmc">PMC2734141</ArticleId><ArticleId IdType="pubmed">18458169</ArticleId></ArticleIdList></Reference><Reference><Citation>Muris D.M., Houben A.J., Schram M.T., Stehouwer C.D. Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus. Arterioscler. Thromb. Vasc. Biol. 2012;32:3082&#x2013;3094. doi: 10.1161/ATVBAHA.112.300291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.112.300291</ArticleId><ArticleId IdType="pubmed">23042819</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro T., Ebert S.M., Adams C.M., Rasmussen B.B. Amino Acid Sensing in Skeletal Muscle. Trends Endocrinol. Metab. 2016;27:796&#x2013;806. doi: 10.1016/j.tem.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2016.06.010</ArticleId><ArticleId IdType="pmc">PMC5075248</ArticleId><ArticleId IdType="pubmed">27444066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafeiridis A., Triantafyllou A., Papadopoulos S., Koletsos N., Touplikioti P., Zafeiridis A.S., Gkaliagkousi E., Dipla K., Douma S. Dietary nitrate improves muscle microvascular reactivity and lowers blood pressure at rest and during isometric exercise in untreated hypertensives. Microcirculation. 2019;26:e12525. doi: 10.1111/micc.12525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/micc.12525</ArticleId><ArticleId IdType="pubmed">30586209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers E.M., Banks N.F., Jenkins N.D.M. Metabolic and microvascular function assessed using near-infrared spectroscopy with vascular occlusion in women: Age differences and reliability. Exp. Physiol. 2023;108:123&#x2013;134. doi: 10.1113/EP090540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090540</ArticleId><ArticleId IdType="pmc">PMC10103776</ArticleId><ArticleId IdType="pubmed">36420592</ArticleId></ArticleIdList></Reference><Reference><Citation>Citherlet T., Raberin A., Manferdelli G., Mota G.R., Millet G.P. Age and sex differences in microvascular responses during reactive hyperaemia. Exp. Physiol. 2024;109:804&#x2013;811. doi: 10.1113/EP091652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP091652</ArticleId><ArticleId IdType="pmc">PMC11061625</ArticleId><ArticleId IdType="pubmed">38509637</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi M., Okita K. Microvascular responses during reactive hyperemia assessed by near-infrared spectroscopy and arterial stiffness in young, middle-aged, and older women. Microvasc. Res. 2020;129:103972. doi: 10.1016/j.mvr.2019.103972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2019.103972</ArticleId><ArticleId IdType="pubmed">31891717</ArticleId></ArticleIdList></Reference><Reference><Citation>Dipla K., Triantafyllou A., Grigoriadou I., Kintiraki E., Triantafyllou G.A., Poulios P., Vrabas I.S., Zafeiridis A., Douma S., Goulis D.G. Impairments in microvascular function and skeletal muscle oxygenation in women with gestational diabetes mellitus: Links to cardiovascular disease risk factors. Diabetologia. 2017;60:192&#x2013;201. doi: 10.1007/s00125-016-4129-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4129-7</ArticleId><ArticleId IdType="pubmed">27722775</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvares T.S., Pinheiro V., Gomes T., Murias J.M., Nogueira Soares R. Vasculature of older females shows heterogeneity in the association between cardiovascular risk and vascular function. Am. J. Physiol. Heart Circ. Physiol. 2025;328:H93&#x2013;H100. doi: 10.1152/ajpheart.00731.2024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00731.2024</ArticleId><ArticleId IdType="pubmed">39620900</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander Y., Osto E., Schmidt-Trucks&#xe4;ss A., Shechter M., Trifunovic D., Duncker D.J., Aboyans V., B&#xe4;ck M., Badimon L., Cosentino F. Endothelial function in cardiovascular medicine: A consensus paper of the European society of cardiology working groups on atherosclerosis and vascular biology, aorta and peripheral vascular diseases, coronary pathophysiology and microcirculation, and thrombosis. Cardiovasc. Res. 2021;117:29&#x2013;42. doi: 10.1093/cvr/cvaa085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa085</ArticleId><ArticleId IdType="pmc">PMC7797212</ArticleId><ArticleId IdType="pubmed">32282914</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;vamees O., Shemyakin A., Checa A., Wheelock C.E., Lundberg J.O., &#xd6;stenson C.-G., Pernow J. Arginase inhibition improves microvascular endothelial function in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2016;101:3952&#x2013;3958. doi: 10.1210/jc.2016-2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2016-2007</ArticleId><ArticleId IdType="pubmed">27399350</ArticleId></ArticleIdList></Reference><Reference><Citation>Virdis A., Masi S., Colucci R., Chiriaco M., Uliana M., Puxeddu I., Bernardini N., Blandizzi C., Taddei S. Microvascular Endothelial Dysfunction in Patients with Obesity. Curr. Hypertens. Rep. 2019;21:32. doi: 10.1007/s11906-019-0930-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-019-0930-2</ArticleId><ArticleId IdType="pubmed">30949772</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz D.E., White R., Li D., Minhas K.M., Cernetich A., Kim S., Burke S., Shoukas A.A., Nyhan D., Champion H.C. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003;108:2000&#x2013;2006. doi: 10.1161/01.CIR.0000092948.04444.C7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000092948.04444.C7</ArticleId><ArticleId IdType="pubmed">14517171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Bugaj L.J., Oh Y.J., Bivalacqua T.J., Ryoo S., Soucy K.G., Santhanam L., Webb A., Camara A., Sikka G., et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. (1985) 2009;107:1249&#x2013;1257. doi: 10.1152/japplphysiol.91393.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.91393.2008</ArticleId><ArticleId IdType="pmc">PMC2763842</ArticleId><ArticleId IdType="pubmed">19661445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokarz J., Moller G., Artati A., Huber S., Zeigerer A., Blaauw B., Adamski J., Dyar K.A. Common Muscle Metabolic Signatures Highlight Arginine and Lysine Metabolism as Potential Therapeutic Targets to Combat Unhealthy Aging. Int. J. Mol. Sci. 2021;22:7958. doi: 10.3390/ijms22157958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157958</ArticleId><ArticleId IdType="pmc">PMC8348621</ArticleId><ArticleId IdType="pubmed">34360722</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Poll M.C., Siroen M.P., van Leeuwen P.A., Soeters P.B., Melis G.C., Boelens P.G., Deutz N.E., Dejong C.H. Interorgan amino acid exchange in humans: Consequences for arginine and citrulline metabolism. Am. J. Clin. Nutr. 2007;85:167&#x2013;172. doi: 10.1093/ajcn/85.1.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/85.1.167</ArticleId><ArticleId IdType="pubmed">17209193</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hattab A.W., Emrick L.T., Hsu J.W., Chanprasert S., Almannai M., Craigen W.J., Jahoor F., Scaglia F. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation. Mol. Genet. Metab. 2016;117:407&#x2013;412. doi: 10.1016/j.ymgme.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2016.01.010</ArticleId><ArticleId IdType="pmc">PMC4818739</ArticleId><ArticleId IdType="pubmed">26851065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatanawi A., Momani M.S., Al-Aqtash R., Hamdan M.H., Gharaibeh M.N. L-Citrulline Supplementation Increases Plasma Nitric Oxide Levels and Reduces Arginase Activity in Patients with Type 2 Diabetes. Front. Pharmacol. 2020;11:584669. doi: 10.3389/fphar.2020.584669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.584669</ArticleId><ArticleId IdType="pmc">PMC7783447</ArticleId><ArticleId IdType="pubmed">33414716</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Bassossy H.M., El-Fawal R., Fahmy A. Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production. Vasc. Pharmacol. 2012;57:194&#x2013;200. doi: 10.1016/j.vph.2012.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2012.01.001</ArticleId><ArticleId IdType="pubmed">22281732</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero M.J., Platt D.H., Tawfik H.E., Labazi M., El-Remessy A.B., Bartoli M., Caldwell R.B., Caldwell R.W. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ. Res. 2008;102:95&#x2013;102. doi: 10.1161/CIRCRESAHA.107.155028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.107.155028</ArticleId><ArticleId IdType="pmc">PMC2822539</ArticleId><ArticleId IdType="pubmed">17967788</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj A., Fischer S.M., Dillon K.N., Kang Y., Martinez M.A., Figueroa A. Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women. Nutrients. 2022;14:4396. doi: 10.3390/nu14204396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204396</ArticleId><ArticleId IdType="pmc">PMC9609406</ArticleId><ArticleId IdType="pubmed">36297080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y., Dillon K.N., Martinez M.A., Maharaj A., Fischer S.M., Figueroa A. Combined L-Citrulline Supplementation and Slow Velocity Low-Intensity Resistance Training Improves Leg Endothelial Function, Lean Mass, and Strength in Hypertensive Postmenopausal Women. Nutrients. 2023;15:74. doi: 10.3390/nu15010074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15010074</ArticleId><ArticleId IdType="pmc">PMC9823738</ArticleId><ArticleId IdType="pubmed">36615732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratchford S.M., Bunsawat K., Alpenglow J.K., Zhao J., Wright J.B., Ryan J.J., Wray D.W. Improved Vascular Function and Functional Capacity Following L-Citrulline Administration in Patients with HFpEF: A Single-arm, Open-label Pilot Study. J. Appl. Physiol. (1985) 2022;134:328&#x2013;338. doi: 10.1152/japplphysiol.00445.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00445.2022</ArticleId><ArticleId IdType="pmc">PMC9886346</ArticleId><ArticleId IdType="pubmed">36476159</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberry R., Munson M., Chung S., Samuel T.J., Patik J., Tucker W.J., Haykowsky M.J., Nelson M.D. Age-related microvascular dysfunction: Novel insight from near-infrared spectroscopy. Exp. Physiol. 2018;103:190&#x2013;200. doi: 10.1113/EP086639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP086639</ArticleId><ArticleId IdType="pubmed">29114952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fryk E., Rodrigues Silva V.R., Bauza-Thorbrugge M., Schmelz M., Gan L.M., Strindberg L., Jansson P.A. Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): A single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial. EClinicalMedicine. 2023;59:101985. doi: 10.1016/j.eclinm.2023.101985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101985</ArticleId><ArticleId IdType="pmc">PMC10225663</ArticleId><ArticleId IdType="pubmed">37256099</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruy&#xe8;re O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16&#x2013;31. doi: 10.1093/ageing/afy169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afy169</ArticleId><ArticleId IdType="pmc">PMC6322506</ArticleId><ArticleId IdType="pubmed">30312372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttolomondo A., Casuccio A., Guercio G., Maida C., Del Cuore A., Di Raimondo D., Simonetta I., Di Bona D., Pecoraro R., Della Corte V., et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc. Diabetol. 2017;16:2. doi: 10.1186/s12933-016-0483-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0483-5</ArticleId><ArticleId IdType="pmc">PMC5217198</ArticleId><ArticleId IdType="pubmed">28056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo B.K., Chung W.Y., Moon M.K. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: A prospective cohort study. Cardiovasc. Diabetol. 2020;19:82. doi: 10.1186/s12933-020-01062-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01062-z</ArticleId><ArticleId IdType="pmc">PMC7293773</ArticleId><ArticleId IdType="pubmed">32534580</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Jasmi F., Al Zaabi N., Al-Thihli K., Al Teneiji A.M., Hertecant J., El-Hattab A.W. Endothelial Dysfunction and the Effect of Arginine and Citrulline Supplementation in Children and Adolescents With Mitochondrial Diseases. J. Cent. Nerv. Syst. Dis. 2020;12:1179573520909377. doi: 10.1177/1179573520909377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179573520909377</ArticleId><ArticleId IdType="pmc">PMC7050027</ArticleId><ArticleId IdType="pubmed">32165851</ArticleId></ArticleIdList></Reference><Reference><Citation>Orea-Tejeda A., Orozco-Gutierrez J.J., Castillo-Martinez L., Keirns-Davies C., Montano-Hernandez P., Vazquez-Diaz O., Valdespino-Trejo A., Infante O., Martinez-Memije R. The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction. Cardiol. J. 2010;17:464&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">20865676</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaqr R., Skleres M., Jayswal R., Thomas D.T. The effect of dietary nitrate and vitamin C on endothelial function, oxidative stress and blood lipids in untreated hypercholesterolemic subjects: A randomized double-blind crossover study. Clin. Nutr. 2021;40:1851&#x2013;1860. doi: 10.1016/j.clnu.2020.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.10.012</ArticleId><ArticleId IdType="pubmed">33115598</ArticleId></ArticleIdList></Reference><Reference><Citation>Litwin N.S., Van Ark H.J., Hartley S.C., Michell K.A., Vazquez A.R., Fischer E.K., Melby C.L., Weir T.L., Wei Y., Rao S., et al. Impact of Red Beetroot Juice on Vascular Endothelial Function and Cardiometabolic Responses to a High-Fat Meal in Middle-Aged/Older Adults with Overweight and Obesity: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Curr. Dev. Nutr. 2019;3:nzz113. doi: 10.1093/cdn/nzz113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cdn/nzz113</ArticleId><ArticleId IdType="pmc">PMC6848269</ArticleId><ArticleId IdType="pubmed">31737860</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilchrist M., Winyard P.G., Aizawa K., Anning C., Shore A., Benjamin N. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic. Biol. Med. 2013;60:89&#x2013;97. doi: 10.1016/j.freeradbiomed.2013.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.01.024</ArticleId><ArticleId IdType="pubmed">23395779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen J., Lu H., Wang X.Q., Vaziri N.D., Zhou X.J. Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am. J. Hypertens. 2008;21:28&#x2013;34. doi: 10.1038/ajh.2007.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2007.14</ArticleId><ArticleId IdType="pubmed">18091741</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuan C., Lun L.-M., Zhao J.-X., Wang H.-W., Wang J., Ning C.-P., Liu Z., Zhang B.-B., He G.-W. L-citrulline for protection of endothelial function from ADMA&#x2013;induced injury in porcine coronary artery. Sci. Rep. 2015;5:10987. doi: 10.1038/srep10987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10987</ArticleId><ArticleId IdType="pmc">PMC4457144</ArticleId><ArticleId IdType="pubmed">26046576</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares R.N., Murias J.M. Near-infrared spectroscopy assessment of microvasculature detects difference in lower limb vascular responsiveness in obese compared to lean individuals. Microvasc. Res. 2018;118:31&#x2013;35. doi: 10.1016/j.mvr.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2018.01.008</ArticleId><ArticleId IdType="pubmed">29408423</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Roux-Mallouf T., Pelen F., Vallejo A., Halimaoui I., Doutreleau S., Verges S. Effect of chronic nitrate and citrulline supplementation on vascular function and exercise performance in older individuals. Aging. 2019;11:3315&#x2013;3332. doi: 10.18632/aging.101984.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101984</ArticleId><ArticleId IdType="pmc">PMC6555465</ArticleId><ArticleId IdType="pubmed">31141497</ArticleId></ArticleIdList></Reference><Reference><Citation>Volino-Souza M., Oliveira G.V., Pinheiro V.D.S., Conte-Junior C.A., Alvares T.D.S. The effect of dietary nitrate on macro- and microvascular function: A systematic review. Crit. Rev. Food Sci. Nutr. 2024;64:1225&#x2013;1236. doi: 10.1080/10408398.2022.2113989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2113989</ArticleId><ArticleId IdType="pubmed">36062809</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa A., Maharaj A., Kang Y., Dillon K.N., Martinez M.A., Morita M., Nogimura D., Fischer S.M. Combined Citrulline and Glutathione Supplementation Improves Endothelial Function and Blood Pressure Reactivity in Postmenopausal Women. Nutrients. 2023;15:1557. doi: 10.3390/nu15071557.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15071557</ArticleId><ArticleId IdType="pmc">PMC10097312</ArticleId><ArticleId IdType="pubmed">37049398</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwedhelm E., Maas R., Freese R., Jung D., Lukacs Z., Jambrecina A., Spickler W., Schulze F., Boger R.H. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: Impact on nitric oxide metabolism. Br. J. Clin. Pharmacol. 2008;65:51&#x2013;59. doi: 10.1111/j.1365-2125.2007.02990.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2007.02990.x</ArticleId><ArticleId IdType="pmc">PMC2291275</ArticleId><ArticleId IdType="pubmed">17662090</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti L.D., Casiraghi M.C., Setola E., Galluccio E., Pagani M.A., Quaglia L., Bosi E., Piatti P. L-arginine enriched biscuits improve endothelial function and glucose metabolism: A pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism. 2013;62:255&#x2013;264. doi: 10.1016/j.metabol.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2012.08.004</ArticleId><ArticleId IdType="pubmed">23040413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues-Krause J., Krause M., Rocha I.M.G.d., Umpierre D., Fayh A.P.T. Association of l-arginine supplementation with markers of endothelial function in patients with cardiovascular or metabolic disorders: A systematic review and meta-analysis. Nutrients. 2019;11:15. doi: 10.3390/nu11010015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11010015</ArticleId><ArticleId IdType="pmc">PMC6357192</ArticleId><ArticleId IdType="pubmed">30577559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamburg N.M., Palmisano J., Larson M.G., Sullivan L.M., Lehman B.T., Vasan R.S., Levy D., Mitchell G.F., Vita J.A., Benjamin E.J. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension. 2011;57:390&#x2013;396. doi: 10.1161/HYPERTENSIONAHA.110.160812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.110.160812</ArticleId><ArticleId IdType="pmc">PMC3049726</ArticleId><ArticleId IdType="pubmed">21263120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajecki D., Gawry&#x15b; J., Wi&#x15b;niewski J., Fortuna P., Szahidewicz-Krupska E., Doroszko A. A cross-talk between the erythrocyte l-arginine/ADMA/nitric oxide metabolic pathway and the endothelial function in subjects with Type 2 diabetes mellitus. Nutrients. 2021;13:2306. doi: 10.3390/nu13072306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072306</ArticleId><ArticleId IdType="pmc">PMC8308357</ArticleId><ArticleId IdType="pubmed">34371816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdi A., Kovamees O., Pernow J. Improvement in endothelial function in cardiovascular disease&#x2014;Is arginase the target? Int. J. Cardiol. 2020;301:207&#x2013;214. doi: 10.1016/j.ijcard.2019.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.11.004</ArticleId><ArticleId IdType="pubmed">31785959</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante W., Johnson F.K., Johnson R.A. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 2007;34:906&#x2013;911. doi: 10.1111/j.1440-1681.2007.04638.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2007.04638.x</ArticleId><ArticleId IdType="pmc">PMC1955221</ArticleId><ArticleId IdType="pubmed">17645639</ArticleId></ArticleIdList></Reference><Reference><Citation>Beleznai T., Feher A., Spielvogel D., Lansman S.L., Bagi Z. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am. J. Physiol. Heart Circ. Physiol. 2011;300:H777&#x2013;H783. doi: 10.1152/ajpheart.00831.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00831.2010</ArticleId><ArticleId IdType="pmc">PMC3064303</ArticleId><ArticleId IdType="pubmed">21217072</ArticleId></ArticleIdList></Reference><Reference><Citation>Tengbom J., Kontidou E., Collado A., Yang J., Alvarsson M., Brinck J., Rossner S., Zhou Z., Pernow J., Mahdi A. Differences in endothelial function between patients with Type 1 and Type 2 diabetes: Effects of red blood cells and arginase. Clin. Sci. 2024;138:975&#x2013;985. doi: 10.1042/CS20240447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20240447</ArticleId><ArticleId IdType="pmc">PMC11300671</ArticleId><ArticleId IdType="pubmed">39037711</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpato S., Bianchi L., Lauretani F., Lauretani F., Bandinelli S., Guralnik J.M., Zuliani G., Ferrucci L. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care. 2012;35:1672&#x2013;1679. doi: 10.2337/dc11-2202.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc11-2202</ArticleId><ArticleId IdType="pmc">PMC3402248</ArticleId><ArticleId IdType="pubmed">22596176</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Garcia A., Pascual-Fernandez J., Noriega-Gonzalez D.C., Bello H.J., Pons-Biescas A., Roche E., Cordova-Martinez A. L-Citrulline Supplementation and Exercise in the Management of Sarcopenia. Nutrients. 2021;13:3133. doi: 10.3390/nu13093133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093133</ArticleId><ArticleId IdType="pmc">PMC8465698</ArticleId><ArticleId IdType="pubmed">34579009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura G., Noirez P., Breuill&#xe9; D., Godin J., Pinaud S., Cleroux M., Choisy C., Le Pl&#xe9;nier S., Bastic V., Neveux N. Effect of citrulline on muscle functions during moderate dietary restriction in healthy adult rats. Amino Acids. 2013;45:1123&#x2013;1131. doi: 10.1007/s00726-013-1564-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-013-1564-3</ArticleId><ArticleId IdType="pubmed">23913268</ArticleId></ArticleIdList></Reference><Reference><Citation>Heubel A.D., Kabbach E.Z., Migliato G.R., Russo M.I.S., Brandao G.M.S., Roscani M.G., Borghi-Silva A., Mendes R.G. Role of arterial stiffness and endothelial dysfunction on lower limb performance in older adults with type 2 diabetes: A cross-sectional study. J. Diabetes Complicat. 2022;36:108260. doi: 10.1016/j.jdiacomp.2022.108260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108260</ArticleId><ArticleId IdType="pubmed">35842303</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerland M., Kales A., Schrier L., Van Dongen M., Bradnock D., Burggraaf J. Evaluation of the EndoPAT as a tool to assess endothelial function. Int. J. Vasc. Med. 2012;2012:904141. doi: 10.1155/2012/904141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/904141</ArticleId><ArticleId IdType="pmc">PMC3303545</ArticleId><ArticleId IdType="pubmed">22500237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V., Pavlidis G., Kousathana F., Maratou E., Georgiou D., Andreadou I., Kountouri A., Varoudi M., Balampanis K., Parissis J., et al. Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study. J. Clin. Med. 2019;8:983. doi: 10.3390/jcm8070983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8070983</ArticleId><ArticleId IdType="pmc">PMC6678085</ArticleId><ArticleId IdType="pubmed">31284526</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>